Latest News & Updates

Breaking News

  • 21 hours ago

  • Simantini Singh Deo

FDA Clears 131 Drugs in 2025 as Global Approval Momentum Surpasses Decade Average
Breaking News
Sanofi Gains Japan MHLW Approval for Wayrilz in Immune Thrombocytopenia Following Phase 3 Data

Simantini Singh Deo

Other trending news you may like to read

FDA Clears 131 Drugs in 2025 as Global Approval Momentum Surpasses Decade Average

FDA cleared 131 drugs in 2025, surpassing the 10-year average and intensifying manufacturing scale-up and CMO capacity demands.

Simantini Singh Deo

Pharma Now

Sanofi Gains Japan MHLW Approval for Wayrilz in Immune Thrombocytopenia Following Phase 3 Data

Japan's MHLW grants Sanofi dual marketing and manufacturing authorization for Wayrilz in ITP, based on LUNA 3 phase 3 data.

Simantini Singh Deo

Pharma Now

Sanofi Gains EU Approval for Cenrifki as First Disability-Targeting Therapy in Non-Relapsing SPMS

Sanofi's Cenrifki gains EC approval for non-relapsing SPMS, introducing mandatory liver monitoring and a phased EU launch starting in Germany.

Simantini Singh Deo

Pharma Now

AbbVie Gains EC Approval for SKYRIZI in Pediatric Plaque Psoriasis with New Weight-Based Pre-Filled Syringe

EC approves AbbVie's risankizumab for pediatric psoriasis, introducing a 55 mg weight-based pre-filled syringe for patients under 40 kg.

Simantini Singh Deo

Pharma Now